142 related articles for article (PubMed ID: 12098008)
1. Aerosol orgotein (Ontosein) for the prevention of radiotherapy-induced adverse effects in head and neck cancer patients: a feasibility study.
Escribano A; García-Grande A; Montañés P; Miralles L; García A
Neoplasma; 2002; 49(3):201-8. PubMed ID: 12098008
[TBL] [Abstract][Full Text] [Related]
2. Orgotein efficacy in ameliorating side effects due to radiation therapy.
Edsmyr F; Menander-Huber KB
Eur J Rheumatol Inflamm; 1981; 4(2):228-36. PubMed ID: 7044789
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
[TBL] [Abstract][Full Text] [Related]
4. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.
Rades D; Fehlauer F; Bajrovic A; Mahlmann B; Richter E; Alberti W
Radiother Oncol; 2004 Mar; 70(3):261-4. PubMed ID: 15064010
[TBL] [Abstract][Full Text] [Related]
5. Prevention of radioinduced cystitis by orgotein: a randomized study.
Sanchiz F; Millá A; Artola N; Julià JC; Moya LM; Pedro A; Vila A
Anticancer Res; 1996; 16(4A):2025-8. PubMed ID: 8712737
[TBL] [Abstract][Full Text] [Related]
6. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.
Anné PR
Semin Oncol; 2002 Dec; 29(6 Suppl 19):80-3. PubMed ID: 12577250
[TBL] [Abstract][Full Text] [Related]
8. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of orgotein in prevention of late side effects of pelvic irradiation: a randomized study.
Esco R; Valencia J; Coronel P; Carceller JA; Gimeno M; Bascón N
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1211-9. PubMed ID: 15519794
[TBL] [Abstract][Full Text] [Related]
10. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T
Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
[TBL] [Abstract][Full Text] [Related]
12. Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function.
Veerasarn V; Phromratanapongse P; Suntornpong N; Lorvidhaya V; Sukthomya V; Chitapanarux I; Tesavibul C; Swangsilpa T; Khorprasert C; Shotelersuk K; Kongthanarat Y; Panichevaluk A; Chiewvit S; Pusuwan P; Aekmahachai M; Ratchadara S; Sirilipoche S; Saengsuda Y
J Med Assoc Thai; 2006 Dec; 89(12):2056-67. PubMed ID: 17214057
[TBL] [Abstract][Full Text] [Related]
13. Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up study.
Büntzel J; Glatzel M; Mücke R; Micke O; Bruns F
Anticancer Res; 2007; 27(4A):1953-6. PubMed ID: 17649803
[TBL] [Abstract][Full Text] [Related]
14. Orgotein efficacy in ameliorating side effects due to radiation therapy.
Menander-Huber KB; Edsmyr F; Huber W
Scand J Urol Nephrol Suppl; 1980; 55():219-24. PubMed ID: 6938029
[No Abstract] [Full Text] [Related]
15. The efficacy of orgotein in the treatment of acute toxicity due to radiotherapy on head and neck tumors.
Valencia J; Velilla C; Urpegui A; Alvarez I; Llorens MA; Coronel P; Polo S; Bascón N; Escó R
Tumori; 2002; 88(5):385-9. PubMed ID: 12487556
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Cepharanthin to prevent radiation induced xerostomia in head and neck cancer].
Imada H; Nomoto S; Ohguri T; Yahara K; Kato F; Morioka T; Korogi Y
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1041-5. PubMed ID: 15272582
[TBL] [Abstract][Full Text] [Related]
17. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
de Castro G; Federico MH
Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of oral recombinant human granulocyte macrophage-colony stimulating factor in radiotherapy-induced esophagitis.
Koc M; Onuk MD; Koruk M; Memik F
Hepatogastroenterology; 2003; 50(53):1297-300. PubMed ID: 14571722
[TBL] [Abstract][Full Text] [Related]
19. [The second phase clinical observation of anti-radiation effect by superoxide dismutase].
Tu Q; Tang J; Shen L; Lei Y; Yu S; Zhou J; He J; Chen C; Zhang F; Zhang F; Dong F; Peng H; Tan H
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(3):308-10. PubMed ID: 10681768
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy.
Metz JM; Smith D; Mick R; Lustig R; Mitchell J; Cherakuri M; Glatstein E; Hahn SM
Clin Cancer Res; 2004 Oct; 10(19):6411-7. PubMed ID: 15475427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
